Riders · The University of Texas Health Science Center at San Antonio · Article III: Agencies of Education

Opioid Abuse Prevention and Treatment

Rider 6 in the 2026-27 Act, page III-233

Through the session

  1. 2024-25 Act Not in this version
  2. Introduced (Senate) Not in this version
  3. Introduced (House) Not in this version
  4. Senate substitute Not in this version
  5. House substitute New rider 5
  6. House passed Unchanged rider 5
  7. Conference Amended rider 6
  8. 2026-27 Act Unchanged rider 6

Pick any two steps to compare their wording.

What changed in the text

House passed → Conference: 6 passages changed.

Opioid Abuse Prevention and Treatment. Out of funds appropriated above in Strategy E.2.1, Opioid Abuse Prevention, $9,100,000 in fiscal year 2026 and $9,100,000 in fiscal year 2027 from GR-Dedicated Account No. 5189 shall be used to support efforts that include, but are not limited to, funding for overdose reversal medication access for law enforcement, distribution through health care providers, educational programming and distribution through schools, and distribution through community organizations. It is the intent of the Legislature that his this funding stream be considered to supplement opioid abuse prevention activities for subsequent biennia. By November 1, 2026, The University of Texas Health Science Center at San Antonio shall submit a report to the Legislative Budget Board, the Office of the Governor, the Senate Finance Committee, and the House Appropriations Committee detailing the expenditure of funds appropriated in Strategy E.2.1, Opioid Abuse Prevention, Prevention during fiscal year 2026. The report shall contain, at a minimum, metrics that mirror information contractually required to be submitted to the Health and Human Services Commission in order to inform of any future appropriations. Any unexpended or unobligated balances remaining as of August 31, 2026, are appropriated for the same purpose for the fiscal year beginning on September 1, 2026.

Removed words are struck through; added words are underlined. Sources: House passed · Conference.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium Not in this version
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) Not in this version
Introduced (House)House Bill 1 as introduced (LBB recommended, House) Not in this version
Senate substituteCommittee Substitute for Senate Bill 1 Not in this version
House substituteHouse Committee Substitute for Senate Bill 1 5 New New Page III-196
House passedSenate Bill 1 as passed the second house 5 Unchanged New Page III-196
ConferenceConference Committee Report for Senate Bill 1 6 was 5 Amended New Page III-209
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium 6 Unchanged New Page III-233
Full text of each wording

Conference, 2026-27 Act

Source, page III-233

Opioid Abuse Prevention and Treatment. Out of funds appropriated above in Strategy E.2.1, Opioid Abuse Prevention, $9,100,000 in fiscal year 2026 and $9,100,000 in fiscal year 2027 from GR-Dedicated Account No. 5189 shall be used to support efforts that include, but are not limited to, funding for overdose reversal medication access for law enforcement, distribution through health care providers, educational programming and distribution through schools, and distribution through community organizations. It is the intent of the Legislature that this funding stream be considered to supplement opioid abuse prevention activities for subsequent biennia. By November 1, 2026, The University of Texas Health Science Center at San Antonio shall submit a report to the Legislative Budget Board, the Office of the Governor, the Senate Finance Committee, and the House Appropriations Committee detailing the expenditure of funds appropriated in Strategy E.2.1, Opioid Abuse Prevention during fiscal year 2026. The report shall contain, at a minimum, metrics that mirror information contractually required to be submitted to the Health and Human Services Commission in order to inform any future appropriations. Any unexpended or unobligated balances remaining as of August 31, 2026, are appropriated for the same purpose for the fiscal year beginning September 1, 2026.

House substitute, House passed

Source, page III-196

Opioid Abuse Prevention and Treatment. Out of funds appropriated above in Strategy E.2.1, Opioid Abuse Prevention, $9,100,000 in fiscal year 2026 and $9,100,000 in fiscal year 2027 from GR-Dedicated Account No. 5189 shall be used to support efforts that include, but are not limited to, funding for overdose reversal medication access for law enforcement, distribution through health care providers, educational programming and distribution through schools, and distribution through community organizations. It is the intent of the Legislature that his funding stream be considered to supplement opioid abuse prevention activities for subsequent biennia. By November 1, 2026, The University of Texas Health Science Center at San Antonio shall submit a report to the Legislative Budget Board, the Office of the Governor, the Senate Finance Committee, and the House Appropriations Committee detailing the expenditure of funds appropriated in Strategy E.2.1, Opioid Abuse Prevention, during fiscal year 2026. The report shall contain, at a minimum, metrics that mirror information contractually required to be submitted to the Health and Human Services Commission in order to inform of any future appropriations. Any unexpended balances as of August 31, 2026, are appropriated for the same purpose for the fiscal year beginning on September 1, 2026.